26-A-8397-ACC EFFICACY AND SAFETY OF LERODALCIBEP IN CHINESE PATIENTS WITH HYPERCHOLESTEROLEMIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL

View at publisher Summarise with VIRAT
Authors: Beijian Chen, Zhaohui Pei, Zhouqing Huang, Shu Zhang, H L Cui, Guanzhong Zheng, DAOQUAN PENG, Hui Xu, Chengchun Tang, PING ZHANG, Cheng Zhang, Na‐Qiong Wu
+11 more 张培东, Jianping Zhang, Yujie Zhou, Guangyao Zhai, Weihong Jiang, Zhiyu Ling, Xiaogang Hui, Lei Zhang, Shuang Chang, Meng Liu, Yong Huo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Cholesterol and Lipid Metabolism Blood Pressure and Hypertension Studies

Publication details

Journal / source
Journal of the American College of Cardiology
Volume
87
Issue
13
Pages
A166–A166
Publication date
27 March 2026
Language
EN